Tonix Pharmaceuticals R&D pact with U.S. Army to be terminated 'without cause'

📆 4/19/2019 2:09 PM
📰 MarketWatch

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 97%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Tonix Pharmaceuticals Holding Corp. disclosed Friday that the U.S. Army Medical Material Development Activity (USAMMDA) is exercising its right to "terminate without cause" the research and development agreement with the company. The termination of the agreement, which Tonix and USAMMDA entered in December 2015, is effective April 29. Tonix has two development programs focused on post-traumatic stress disorder (PTSD), and is currently enrolling participants in a phase 3 trial. The stock has gained 8.2% year to date, but has plunged 93% over the past 12 months, while the S&P 500 has gained 16% year to date and advanced 7.9% the past year.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tracon Pharmaceuticals shares slide 45% premarket after it ends trial of cancer treatmentTracon Pharmaceuticals Inc. shares slid 45% in premarket trade Friday, after the cmpany said it is terminating a late-stage trial of a cancer treatment at...
Source: MarketWatch - 🏆 3. / 97 Read more »

Brunei once held off on sharia law to stay in a U.S.-backed trade pact. Then Trump pulled out.Some rights activists and diplomats contend that Washington has lost leverage in Asia after leaving the Trans-Pacific Partnership. Wow this is a stretch even by today's standards. The WP blaming Trump for something that absolutely has nothing to do with Trump. What a flipping joke. You guys have taken 'sucking' to an entire new level. Wtf what for bs is that
Source: washingtonpost - 🏆 95. / 72 Read more »